The Global AI In Drug Discovery Market Size is Anticipated to Exceed USD 19.9 Billion by 2033, Growing at a CAGR of 38.25% from 2023 to 2033. In drug discovery, artificial intelligence (AI) uses powerful computational algorithms and machine learning models to evaluate biological data, identify possible drug candidates, and speed up the drug development process. AI facilitates the identification of novel drug targets, molecular structure optimization, and huge dataset analysis, all of which help researchers identify new and more effective therapeutic solutions.